|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-8-26
|
|
pubmed:abstractText |
Exit-site infections (ESI) in patients receiving peritoneal dialysis (PD) often progress to tunnel infections and peritonitis, sometimes requiring PD catheter removal. Staphylococcus aureus (SA) is the commonest cause of ESI. In this study, we evaluated the efficacy of mupirocin nasal ointment in preventing ESI in children receiving PD.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0896-8608
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
267-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12938828-Administration, Intranasal,
pubmed-meshheading:12938828-Adolescent,
pubmed-meshheading:12938828-Anti-Bacterial Agents,
pubmed-meshheading:12938828-Carrier State,
pubmed-meshheading:12938828-Catheters, Indwelling,
pubmed-meshheading:12938828-Child,
pubmed-meshheading:12938828-Female,
pubmed-meshheading:12938828-Humans,
pubmed-meshheading:12938828-Male,
pubmed-meshheading:12938828-Mupirocin,
pubmed-meshheading:12938828-Nasal Cavity,
pubmed-meshheading:12938828-Peritoneal Dialysis, Continuous Ambulatory,
pubmed-meshheading:12938828-Staphylococcal Infections,
pubmed-meshheading:12938828-Staphylococcus aureus
|
|
pubmed:articleTitle |
Intranasal mupirocin does not prevent exit-site infections in children receiving peritoneal dialysis.
|
|
pubmed:affiliation |
Department of Nephrology, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan. yaraki@jd6.so-net.ne.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
